induction of HO-1 gene with mesenchymal stem cell therapy in liver fibrosis or cancer initiated by CCl4 treatment in rats is not synergestic.

treatment with MSC is beneficial in liver diseases. HO-1 by itself acting as antioxidant because of bilirubin production is beneficial

09 September 2011 8,436 0 View